727977-57-3

Basic information

• Product Name: 1-(8-METHYL-2-PHENYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID
• Synonyms: 1-(8-METHYL-2-PHENYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID
• CAS NO: 727977-57-3
• Molecular Formula: C21H23N3O2
• Molecular Weight: 349.43
• Mol File: 727977-57-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(8-METHYL-2-PHENYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(8-METHYL-2-PHENYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID(727977-57-3)
• EPA Substance Registry System: 1-(8-METHYL-2-PHENYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-PIPERIDINE-4-CARBOXYLIC ACID(727977-57-3)

Safety Data

• Hazardous Substances Data: 727977-57-3(Hazardous Substances Data)

Usage

Description

1-(8-Methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl-methyl)piperidine-4-carboxylic acid is a complex chemical compound featuring a piperidine ring with a carboxylic acid and an imidazo[1,2-a]pyridin-3-yl-methyl side chain. The imidazo[1,2-a]pyridine portion is a heterocyclic compound with potential biological activity, while the piperidine ring and carboxylic acid group provide additional reactivity and potential binding properties.

Uses

Used in Medicinal Chemistry:
1-(8-Methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl-methyl)piperidine-4-carboxylic acid is used as a compound in medicinal chemistry for its potential diverse biological activities. 1-(8-Methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl-methyl)piperidine-4-carboxylic acid's unique structure and functional groups may allow it to interact with various biological targets, making it a promising candidate for drug discovery and development.
Used in Drug Discovery and Development:
In the pharmaceutical industry, 1-(8-Methyl-2-phenyl-imidazo[1,2-a]pyridin-3-yl-methyl)piperidine-4-carboxylic acid is used as a starting material or a structural component in the design of new drugs. Its heterocyclic nature and functional groups may contribute to the development of novel therapeutic agents with specific targeting capabilities and improved efficacy.